Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson’s disease: post-hoc analysis of a Japanese phase III study

This post-hoc analysis investigated the long-term effects of safinamide on the course of dyskinesia and efficacy outcomes using data from a phase III, open-label 52-week study of safinamide 50 or 100 mg/day in Japanese patients with Parkinson’s disease (PD) with wearing-off. Patients (N = 194) were...

Descripción completa

Detalles Bibliográficos
Autores principales: Hattori, Nobutaka, Kamei, Takanori, Ishida, Takayuki, Suzuki, Ippei, Nomoto, Masahiro, Tsuboi, Yoshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Neurology and Preclinical Neurological Studies - Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468087/
https://www.ncbi.nlm.nih.gov/pubmed/36001147
http://dx.doi.org/10.1007/s00702-022-02532-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468087/
https://www.ncbi.nlm.nih.gov/pubmed/36001147
http://dx.doi.org/10.1007/s00702-022-02532-2

Ejemplares similares